This basic-science animal study tests whether adipose-derived stem cells (ADSCs) can improve tendon-to-bone healing and reverse fatty infiltration after rotator cuff repair. Using a rabbit chronic subscapularis tear model, it compares ADSC injection versus saline, with and without tendon repair, against normal controls. Outcomes were measured by EMG, biomechanical pullout strength, and histologic fat quantification.
Fatty infiltration is one of the strongest predictors of cuff repair failure, and dogma has held it to be irreversible once established. This paper challenges that dogma: local ADSC injection lowered muscle fat content and restored EMG-measured muscle function nearly to normal in a rabbit model.
The key clinical mental model is that biologic augmentation is an ADJUNCT, not a substitute. Every ADSC-only tendon failed to heal without mechanical reattachment, so stem cells help a repaired construct but cannot rescue an unrepaired one.
Weight this evidence carefully. It is a single-timepoint animal study, pullout strength gains were not statistically significant, and repaired tendons never matched native strength. Stem cell benefit for the human cuff remains unproven and contested, with prior MSC studies in rat models showing no structural improvement. Treat this as hypothesis-generating, not practice-changing.
This basic-science animal study tests whether adipose-derived stem cells (ADSCs) can improve tendon-to-bone healing and reverse fatty infiltration after rotator cuff repair. Using a rabbit chronic subscapularis tear model, it compares ADSC injection versus saline, with and without tendon repair, against normal controls. Outcomes were measured by EMG, biomechanical pullout strength, and histologic fat quantification.
Fatty infiltration is one of the strongest predictors of cuff repair failure, and dogma has held it to be irreversible once established. This paper challenges that dogma: local ADSC injection lowered muscle fat content and restored EMG-measured muscle function nearly to normal in a rabbit model.
The key clinical mental model is that biologic augmentation is an ADJUNCT, not a substitute. Every ADSC-only tendon failed to heal without mechanical reattachment, so stem cells help a repaired construct but cannot rescue an unrepaired one.
Weight this evidence carefully. It is a single-timepoint animal study, pullout strength gains were not statistically significant, and repaired tendons never matched native strength. Stem cell benefit for the human cuff remains unproven and contested, with prior MSC studies in rat models showing no structural improvement. Treat this as hypothesis-generating, not practice-changing.